This is a press release from the company, but I thought it was interesting. Blood from volunteer donors between 18-25 years old was collected and the plasma injected into MS patients.
The Neurology Center, in an unprecedented, randomized double-blind, placebo-controlled study, designed to evaluate the efficacy of 25 ml/kg intravenous NuPlasma® young Fresh Frozen Plasma (yFFP®) administered in two doses over three days, realized dramatic improvements in critical disease-conditions such as fatigue, mobility, concentration, and urinary control. These positive initial results reflects the Parkinson's disease (PD) patient results, in which PD patients infused with NuPlasma experienced significant improvements in pain, facial expression, speech, handwriting, tremors, rigidity and falling.
https://www.prnewswire.com/news-rele...300797849.html
The Neurology Center, in an unprecedented, randomized double-blind, placebo-controlled study, designed to evaluate the efficacy of 25 ml/kg intravenous NuPlasma® young Fresh Frozen Plasma (yFFP®) administered in two doses over three days, realized dramatic improvements in critical disease-conditions such as fatigue, mobility, concentration, and urinary control. These positive initial results reflects the Parkinson's disease (PD) patient results, in which PD patients infused with NuPlasma experienced significant improvements in pain, facial expression, speech, handwriting, tremors, rigidity and falling.
https://www.prnewswire.com/news-rele...300797849.html
Comment